Filter
3773
Filtered Results: 3773
Text search:
World
Health
Organization
Africa
Region
Featured
Recommendations
277
New Publications
969
Language
Document type
No document type
2130
Studies & Reports
884
Guidelines
302
Manuals
152
Strategic & Response Plan
142
Fact sheets
58
Training Material
44
Situation Updates
37
Resource Platforms
13
Infographics
9
Brochures
1
Online Courses
1
Countries / Regions
Global
211
Africa
127
Kenya
126
Ethiopia
123
Sierra Leone
115
Liberia
102
Uganda
92
Nigeria
86
Tanzania
77
South Africa
77
Ghana
70
Malawi
67
Zambia
60
Rwanda
55
India
53
Congo, Democratic Republic of
48
West and Central Africa
45
Western and Central Europe
45
Guinea
44
Mozambique
43
Namibia
41
Latin America and the Carribbean
41
East and Southern Africa
40
Middle East and North Africa
40
South Sudan
36
Syria
36
Lesotho
36
Senegal
33
Zimbabwe
32
Nepal
32
Burkina Faso
28
Cameroon
27
Asia
27
South–East Asia Region
26
Botswana
21
Central African Republic
19
Myanmar / Burma
19
Ukraine
18
Benin
17
Eswatini/ Swaziland
17
Yemen
17
Bangladesh
16
Eastern Europe
16
Somalia
15
Sudan
14
Madagascar
14
Afghanistan
13
Russia
13
Mali
12
Pakistan
12
Philippines
11
Cambodia
11
Indonesia
11
Eastern Europe and Central Asia
11
China
9
Colombia
9
Côte d’Ivoire / Ivory Coast
8
Haiti
8
Thailand
8
Venezuela
8
Brazil
7
Western Pacific Region
7
Germany
6
Chad
6
Togo
5
Iraq
5
Gambia
5
Angola
5
Guinea-Bissau
4
Niger
4
Jordan
4
Lebanon
4
Papua New Guinea
4
Burundi
4
Mexico
4
Southern Africa
4
Vietnam
4
North America
4
Morocco
3
North Macedonia
3
Libya
3
Sri Lanka
3
Chile
3
Moldova
3
Iran
3
Georgia
3
Japan
3
Mauritius
3
USA
2
Malaysia
2
Mauritania
2
Argentina
2
Serbia
2
Ecuador
2
Greece
2
Palestine
2
Italy
2
Albania
2
Djibouti
2
Armenia
2
Kyrgyzstan
2
Gabon
2
Tunisia
2
Portugal
2
Bosnia and Herzegovina
2
Saudi Arabia
1
Turkey
1
Egypt
1
Vanuatu
1
Peru
1
Hungary
1
Bolivia
1
Cape Verde
1
Solomon Islands
1
Poland
1
North Korea
1
Laos
1
Congo-Brazzaville
1
Canada
1
Timor Leste/ East Timor
1
Tajikistan
1
Qatar
1
Bulgaria
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Jamaica
1
Belgium
1
United Kingdom
1
Norway
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1280
Clinical Guidelines
298
Public Health
236
Women & Child Health
192
Key Resources
171
Capacity Building
60
Pharmacy & Technologies
36
Annual Report MEDBOX
2
Protection & Security
1
Toolboxes
HIV
340
COVID-19
265
Mental Health
240
Planetary Health
211
TB
192
Ebola
177
Rapid Response
144
Disability
135
NTDs
124
AMR
114
Global Health Education
94
Conflict
90
NCDs
81
Refugee
78
Caregiver
68
Health Financing Toolbox
51
Pharmacy
50
Natural Hazards
42
Zika
33
Polio
31
Cholera
23
Social Ethics
13
Specific Hazards
6
South Sudan
2
Typhoon
1
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und...
Meeting of the Neglected Tropical Diseases Strategic and Technical Advisory
Group’s Monitoring and Evaluation Subgroup on Disease-specific Indicators
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
The World Health Organization's fourth Country Cooperation Strategy 2022-2026 is an outcome of a consultative process with inputs from the Ministry...
Obesity and diet-related noncommunicable diseases (NCDs) have been steadily increasing globally, and with them, a pressing need to implement effective responses to address the contributing factors. Among the available evidence-based policy options that enable healthier choices and improved diets is ...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regi...al reports
Monkeypox
RSV
COVID-19 vaccines
Polio vaccination
Ebola (Sudan ebolavirus outbreak update)
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicabl...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. The disease is endemic in certain areas of the ... Health Organization (WHO) African, South-East Asia and Western Pacific regions. Of the neglected tropical diseases identified for elimination and eradication, yaws is one of two diseases targeted for eradication. In 1949, the Second World Health Assembly adopted resolution WHA2.36, which addresses yaws, bejel and pinta as major public health problems that need attention.
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO ...s and was rapidly replacing Delta worldwide – was considered Omicron has a substantial growth advantage, higher secondary attack rates and a higher observed reproduction number than Delta.
There is now significant evidence that immune evasion contributes to the rapid spread of Omicron. Other factors may be a shorter
serial interval (by about 0.8 to 1.2 days compared to Delta) and potential increased intrinsic transmission fitness . There is
growing evidence that with Omicron, there is lower vaccine effectiveness (VE) against infection and symptomatic disease soon after vaccination compared to Delta. There is also evidence of accelerated waning of VE over time of the primary series against infection and symptomatic disease for the studied vaccines. Further studies are required to better understand the drivers of transmission and declining incidence in various settings. These factors include the intrinsic transmission fitness properties of the virus, degree of immune evasion, vaccination coverage and level of vaccine-derived and post-infection immunity, levels of social mixing and degree of application of public health and social measures (PHSM).
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the vi...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for labora...
En la actualidad, los daños que sufren los pacientes a causa de una atención poco segura constituyen un desafío
importante y creciente para la salud pública mundial y son una de las principales causas de muerte y discapacidad
en todo el mundo. La mayor parte de estos daños son evitables. Ahor...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
